1
Daniel C Budge, David Glass, Alvin Pivowar, Mike Wells, Robert Scheussler: E-mail system with a video e-mail player. Smith Micro Software, Knobbe Martens Olson & Bear, January 11, 2000: US06014689 (117 worldwide citation)

Video messages are created in a manner that allows transparent delivery over any electronic mail (e-mail) system. The audio and video components of the message are recorded, encoded, and synchronously combined into a video message file. A player is selectively attached to the video message file to c ...


2
David Glass, Adnan Abu Dayya: Dual mode service WiFi access control. AT&T Mobility II, Turocy & Watson, December 25, 2012: US08340711 (65 worldwide citation)

Systems and methods are described that facilitate the provision of dual mode services. Access to the dual mode services is controlled by associating a mobile device to an access point. Subscribers are required to provide valid geographical addresses for access points associated with the mobile devic ...


3
Daniel C Budge, David Glass, Alvin Pivowar, Mike Wells, Robert Scheussler: E-mail system with video e-mail player. Smith Micro Software, Knobbe Martens Olson & Bear, May 13, 2003: US06564248 (56 worldwide citation)

Video messages are created in a manner that allows transparent delivery over any electronic mail (e-mail) system. The audio and video components of the message are recorded, encoded, and synchronously combined into a video message file. A player is selectively attached to the video message file to c ...


4
Vivien Wong, Gregory Conn, David Glass: Methods of using hepatocyte growth factor to promote survival, growth and differentiation of motor neurons. Regeneron Pharmaceuticals, Gail M Kempler, Robert J Cobert, November 7, 2000: US06143714 (6 worldwide citation)

The present invention provides for a method of promoting motor neuron survival, growth or differentiation comprising treating motor neurons with an effective amount of HGF. The invention also provides for a method of promoting motor neuron survival, growth or differentiation comprising treating moto ...


5
David Glass, Shou Ih Hu: Methods and compositions using Kloto-FGF23 fusion polypeptides. Novartis, Frank Wu, January 13, 2015: US08932589 (5 worldwide citation)

The present invention is directed to methods, kits and compositions for preventing or treating age-related conditions or metabolic disorders. The Klotho fusion polypeptides of the invention include at least a Klotho protein or an active fragment thereof. In one embodiment, the fusion polypeptide com ...


6
David Glass, Shou Ih Hu: Methods and compositions using FGF23 fusion polypeptides. Novartis, Frank Wu, April 16, 2013: US08420088 (5 worldwide citation)

The present invention is directed to fusion polypeptides comprising Klotho protein or an active fragment thereof and FGF23 or an active fragment thereof.


7
David Glass, Shou Ih Hu: Methods and compositions using Klotho-FGF fusion polypeptides. Novartis, Frank Wu, July 9, 2013: US08481031 (5 worldwide citation)

The present invention is directed to fusion polypeptides comprising Klotho protein or an active fragment thereof and FGF23 or an active fragment thereof.


8
Stephen P Squinto, David Glass, Thomas H Aldrich, Peter DiStefano, Trevor Stitt, Mark E Furth, George D Yancopoulos: Assay systems for trkB neurotrophin activity. Regeneron Pharmaceuticals, Gail M Kempler, April 22, 1997: US05622862 (4 worldwide citation)

The present invention provides for assay systems that may be used to detect and/or measure neurotrophin activity or to identify agents that exhibit neurotrophin-like activity, and for methods of using such assay systems. It is based, at least in part, on the discovery that the trkB protooncogene enc ...


9

10
Jennifer Brogdon, Saar Gill, David Glass, Saad Kenderian, Andreas Loew, Joan Mannick, Michael C Milone, Leon Murphy, David L Porter, Marco Ruella, Yongqiang Wang, Qilong Wu, Jiquan Zhang: Treatment of cancer using a CD123 chimeric antigen receptor. Novartis, The Trustees of the University of Pennsylvania, Lando & Anastasi, November 14, 2017: US09815901

The invention provides compositions and methods for treating diseases associated with expression of CD123. The invention also relates to chimeric antigen receptor (CAR) specific to CD123, vectors encoding the same, and recombinant cells comprising the CD123 CAR. The invention also includes methods o ...



Click the thumbnails below to visualize the patent trend.